Lewis Tanya
Related Filers (4)
- Replimune Group, Inc. (8)
- Karyopharm Therapeutics Inc. (6)
- VION PHARMACEUTICALS INC (2)
- DiaMedica Therapeutics Inc. (2)
- Show More ...
Ownership (18)
4
Thursday, 5/18/2023
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2023
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/6/2023
DiaMedica Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 3/6/2023
DiaMedica Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 5/18/2022
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/5/2022
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/11/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/5/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/1/2021
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/17/2021
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2021
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/4/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/3/2020
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/3/2020
Replimune Group, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 2/7/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/5/2019
Karyopharm Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Friday, 12/12/2008
VION PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Thursday, 12/4/2008
VION PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities